The Cooper Companies, Inc. Increase (Decrease) in Operating Capital
The Cooper Companies, Inc. (COO) reported Increase (Decrease) in Operating Capital of -$111.00 million for the 9-month period ending 2026-07-31, per its 10-Q filed 2026-09-09.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingCapital · last filed 2026-09-09
- The Cooper Companies, Inc. increase (decrease) in operating capital for the quarter ending 2026-07-31 was -$55.50M, a 400.00% decline year-over-year.
- The Cooper Companies, Inc. increase (decrease) in operating capital for the quarter ending 2026-04-30 was -$91.60M, a 155.31% decline year-over-year.
- The Cooper Companies, Inc. increase (decrease) in operating capital for the quarter ending 2026-01-31 was $36.10M, a 52.25% decline year-over-year.
- The Cooper Companies, Inc. increase (decrease) in operating capital for the quarter ending 2025-07-31 was $18.50M, a 62.85% decline year-over-year.
| Period end | Increase (Decrease) in Operating Capital 3 month | Increase (Decrease) in Operating Capital 3 month as first filed | Increase (Decrease) in Operating Capital 6 month | Increase (Decrease) in Operating Capital 6 month as first filed | Increase (Decrease) in Operating Capital 9 month | Increase (Decrease) in Operating Capital 9 month as first filed |
|---|---|---|---|---|---|---|
| 2026-07-31 | -$55.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-09-09 | -$147.10M derived: sum of 2 quarters · filed 2026-09-09 | -$111.00M 10-Q · filed 2026-09-09 | |||
| 2026-04-30 | -$91.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-06-05 | -$55.50M 10-Q · filed 2026-06-05 | ||||
| 2026-01-31 | $36.10M 10-Q · filed 2026-03-06 | |||||
| 2025-07-31 | $18.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-09-09 | $184.10M derived: sum of 2 quarters · filed 2026-09-09 | $259.70M 10-Q · filed 2026-09-09 | |||
| 2025-04-30 | $165.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-06-05 | $241.20M 10-Q · filed 2026-06-05 | ||||
| 2025-01-31 | $75.60M 10-Q · filed 2026-03-06 | |||||
| 2024-07-31 | $49.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-28 | $192.90M derived: sum of 2 quarters · filed 2025-08-28 | $302.50M 10-Q · filed 2025-08-28 | |||
| 2024-04-30 | $143.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-30 | $252.70M 10-Q · filed 2025-05-30 | ||||
| 2024-01-31 | $109.60M 10-Q · filed 2025-03-07 | |||||
| 2023-07-31 | $85.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-29 | $160.80M derived: sum of 2 quarters · filed 2024-08-29 | $188.80M 10-Q · filed 2024-08-29 | |||
| 2023-04-30 | $75.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-31 | $103.00M 10-Q · filed 2024-05-31 | ||||
| 2023-01-31 | $28.00M 10-Q · filed 2024-03-01 | |||||
| 2022-07-31 | -$43.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-31 | $14.90M derived: sum of 2 quarters · filed 2023-08-31 | $8.70M 10-Q · filed 2023-08-31 | |||
| 2022-04-30 | $58.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-06-02 | $52.40M 10-Q · filed 2023-06-02 | ||||
| 2022-01-31 | -$6.20M 10-Q · filed 2023-03-03 | |||||
| 2021-07-31 | $20.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-09-01 | $31.70M derived: sum of 2 quarters · filed 2022-09-01 | $81.60M 10-Q · filed 2022-09-01 | |||
| 2021-04-30 | $11.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-06-03 | $61.40M 10-Q · filed 2022-06-03 | ||||
| 2021-01-31 | $49.90M 10-Q · filed 2022-03-04 | |||||
| 2020-07-31 | $36.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-09-03 | $105.30M derived: sum of 2 quarters · filed 2021-09-03 | $155.90M 10-Q · filed 2021-09-03 | |||
| 2020-04-30 | $69.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-06-04 | $119.80M 10-Q · filed 2021-06-04 | ||||
| 2020-01-31 | $50.60M 10-Q · filed 2021-03-05 | |||||
| 2019-07-31 | $2.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-09-04 | -$31.20M derived: sum of 2 quarters · filed 2020-09-04 | $22.10M 10-Q · filed 2020-09-04 | |||
| 2019-04-30 | -$33.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-06-05 | $19.70M 10-Q · filed 2020-06-05 | ||||
| 2019-01-31 | $53.30M 10-Q · filed 2020-03-06 | |||||
| 2018-07-31 | -$46.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-30 | -$35.90M derived: sum of 2 quarters · filed 2019-08-30 | $141.10M 10-Q · filed 2019-08-30 | |||
| 2018-04-30 | $10.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-31 | $187.60M 10-Q · filed 2019-05-31 | ||||
| 2018-01-31 | $177.00M 10-Q · filed 2019-03-06 | -$177.00M 10-Q · filed 2018-03-09 | ||||
| 2017-07-31 | -$800.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-31 | $89.00M derived: sum of 2 quarters · filed 2018-08-31 | $58.70M 10-Q · filed 2018-08-31 | -$58.70M 10-Q · filed 2017-09-01 | ||
| 2017-04-30 | $89.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-06-08 | $59.50M 10-Q · filed 2018-06-08 | -$59.50M 10-Q · filed 2017-06-02 | |||
| 2017-01-31 | -$30.30M 10-Q · filed 2018-03-09 | |||||
| 2016-07-31 | $7.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-09-01 | -$24.20M derived: sum of 2 quarters · filed 2017-09-01 | -$54.60M 10-Q · filed 2017-09-01 | -$54.63M 10-Q · filed 2016-09-02 | ||
| 2016-04-30 | -$31.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-06-02 | -$61.60M 10-Q · filed 2017-06-02 | -$61.67M 10-Q · filed 2016-06-03 | |||
| 2016-01-31 | -$30.40M 10-Q · filed 2017-03-03 | -$30.39M 10-Q · filed 2016-03-04 | ||||
| 2015-07-31 | $5.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-09-02 | -$3.71M derived: sum of 2 quarters · filed 2016-09-02 | -$59.87M 10-Q · filed 2016-09-02 | |||
| 2015-04-30 | -$9.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-06-03 | -$65.36M 10-Q · filed 2016-06-03 | ||||
| 2015-01-31 | -$56.16M 10-Q · filed 2016-03-04 | |||||
| 2014-07-31 | -$8.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-09-04 | -$1.37M derived: sum of 2 quarters · filed 2015-09-04 | -$60.94M 10-Q · filed 2015-09-04 | |||
| 2014-04-30 | $7.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-06-05 | -$52.50M 10-Q · filed 2015-06-05 | ||||
| 2014-01-31 | -$59.57M 10-Q · filed 2015-03-06 | |||||
| 2013-07-31 | -$7.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-09-05 | -$21.28M derived: sum of 2 quarters · filed 2014-09-05 | -$80.90M 10-Q · filed 2014-09-05 | $80.90M 10-Q · filed 2013-09-06 | ||
| 2013-04-30 | -$13.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-06-06 | -$73.53M 10-Q · filed 2014-06-06 | $73.53M 10-Q · filed 2013-06-07 | |||
| 2013-01-31 | -$59.63M 10-Q · filed 2014-03-07 | $59.63M 10-Q · filed 2013-03-08 | ||||
| 2012-07-31 | $21.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-09-06 | $33.42M derived: sum of 2 quarters · filed 2013-09-06 | $81.70M 10-Q · filed 2013-09-06 | |||
| 2012-04-30 | $11.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-06-07 | $59.85M 10-Q · filed 2013-06-07 | -$59.85M 10-Q · filed 2012-06-08 | |||
| 2012-01-31 | $48.28M 10-Q · filed 2013-03-08 | -$48.28M 10-Q · filed 2012-03-09 | ||||
| 2011-07-31 | $15.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-09-07 | -$290.00K derived: sum of 2 quarters · filed 2012-09-07 | $424.00K 10-Q · filed 2012-09-07 | |||
| 2011-04-30 | -$15.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-06-08 | -$14.91M 10-Q · filed 2012-06-08 | $14.91M 10-Q · filed 2011-06-03 | |||
| 2011-01-31 | $714.00K 10-Q · filed 2012-03-09 | -$714.00K 10-Q · filed 2011-03-04 | ||||
| 2010-07-31 | -$3.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-09-02 | -$23.21M derived: sum of 2 quarters · filed 2011-09-02 | -$23.85M 10-Q · filed 2011-09-02 | |||
| 2010-04-30 | -$19.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-06-03 | -$20.50M 10-Q · filed 2011-06-03 | ||||
| 2010-01-31 | -$645.00K 10-Q · filed 2011-03-04 | |||||
| 2009-07-31 | $16.13M 10-Q · filed 2010-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B |